Effect of a controlled lifestyle intervention on medication use and costs: The Healthy Lifestyle Community Program (cohort 2)
Nutrition and Health · 2025
DOI: 10.1177/02601060231164665 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift Nutrition and Health, 2025. Verfasst von Ragna-Marie Kranz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nutrition, Consumption and Health, Faculty of Natural Sciences, Paderborn University, Paderborn, Germany. Hauptthemen laut MEDLINE: Healthy Lifestyle, Noncommunicable Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Background
Establishing a healthy lifestyle has a great potential to reduce the prevalence of non-communicable diseases (NCDs) and their risk factors. NCDs contribute immensely to the economic costs of the health care system arising from therapy, medication use, and productivity loss.
Aim
The aim of this study was to evaluate the effect of the Healthy Lifestyle Community Program (cohort 2; HLCP-2) on medication use and consequently on medication costs for selected NCDs (diabetes, hypertension, and dyslipidemia).
Methods
Data stem from a 24-month non-randomised, controlled intervention trial aiming to improve risk factors for NCDs. Participants completed questionnaires at six measurement time points assessing medication use, from which costs were calculated. The following medication groups were included in the analysis as NCD medication: glucose-lowering medications (GLM), antihypertensive drugs (AHD) and lipid-lowering drugs (LLD). Statistical tests for inter- and intra-group comparison and multiple regression analysis were performed.
Results
In total, 118 participants (intervention group [IG]: n = 79; control group [CG]: n = 39) were considered. Compared to baseline medication use decreased slightly in the IG and increased in the CG. Costs for NCD medication were significantly lower in the IG than in the CG after 6 ( p = 0.004), 12 ( p = 0.040), 18 ( p = 0.003) and 24 months ( p = 0.008). After multiple regression analysis and adjusting for confounders, change of costs differed significantly between the groups in all final models.
Conclusion
The HLCP-2 was able to moderately prevent an increase of medication use and thus reduce costs for medication to treat NCDs with the greatest impact on AHD.
Trial registration
German Clinical Trials Register DRKS ( www.drks.de ; reference: DRKS00018775).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Nutrition, Consumption and Health, Faculty of Natural Sciences, Paderborn University, Paderborn, Germany.
- Department of Food Nutrition Facilities, University of Applied Sciences Muenster, Muenster, Germany.
ORCID-Profile: Ragna-Marie Kranz, Carmen Kettler
Förderung
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Kranz, R. M., Kettler, C., Anand, C., Koeder, C., Husain, S., Schoch, N., Buyken, A., & Englert, H. (2025). Effect of a controlled lifestyle intervention on medication use and costs: The Healthy Lifestyle Community Program (cohort 2). Nutrition and Health. https://doi.org/10.1177/02601060231164665
Vancouver
Kranz RM, Kettler C, Anand C, Koeder C, Husain S, Schoch N, et al. Effect of a controlled lifestyle intervention on medication use and costs: The Healthy Lifestyle Community Program (cohort 2). Nutrition and Health. 2025. doi:10.1177/02601060231164665
BibTeX
@article{Kranz2025,
author = {Kranz, Ragna-Marie and Kettler, Carmen and Anand, Corinna and Koeder, Christian and Husain, Sarah and Schoch, Nora and Buyken, Anette and Englert, Heike},
title = {Effect of a controlled lifestyle intervention on medication use and costs: The Healthy Lifestyle Community Program (cohort 2)},
journal = {Nutrition and Health},
year = {2025},
doi = {10.1177/02601060231164665}
}
EUVIMED